ACLARIS THERAPEUTICS INC shareholders Q3 2023

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

ACLARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Woodline Partners LP 170,230$1,166,0760.01%
Schonfeld Strategic Advisors LLC 269,746$1,847,7590.01%
Point72 Asset Management, L.P. 662,529$4,538,3240.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 68,014$465,8960.01%
LORD, ABBETT & CO. LLC 453,954$3,1100.01%
BOOTHBAY FUND MANAGEMENT, LLC 73,200$501,4200.01%
SG Americas Securities, LLC 151,704$1,0390.01%
Dynamic Technology Lab Private Ltd 14,135$970.01%
ExodusPoint Capital Management, LP 146,454$1,0030.01%
WELLINGTON MANAGEMENT GROUP LLP 6,979,844$47,811,9320.01%
Pale Fire Capital SE 13,000$89,0500.01%
Renaissance Technologies 647,652$4,4360.01%
Weiss Multi-Strategy Advisers LLC 50,368$3450.01%
MILLENNIUM MANAGEMENT LLC 1,967,980$13,480,6630.01%
CWA Asset Management Group, LLC 14,705$100,7290.01%
Connor, Clark & Lunn Investment Management Ltd. 201,233$1,378,4460.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 175,481$1,202,0450.01%
Engineers Gate Manager LP 25,470$174,4700.01%
PROFUND ADVISORS LLC 13,098$89,7210.01%
SILVERARC CAPITAL MANAGEMENT, LLC 2,400$16,4400.01%
External links

This page lists ACLARIS THERAPEUTICS INC's shareholders in Q3 2023. To view ACLARIS THERAPEUTICS INC's shareholder history, click here.